Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.
You can find text and video tutorials here that explain how to use our system.
SYNACT PHARMA ApS
CVR number: 34459975
Dronninggårds Alle 136, 2840 Holte
joo@txppharma.com
tel: 28447567
Income statement (kDKK)
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Other operating income | 447.26 | ||||
| Purchases during the financial year | -15 850.96 | ||||
| External services | -1 406.21 | ||||
| Gross profit | -16 809.90 | -11 468.38 | -16 674.00 | -43 429.98 | -46 951.48 |
| Employee benefit expenses | -2 647.44 | -7 454.00 | |||
| Total depreciation | - 220.59 | - 238.67 | - 287.00 | - 472.09 | - 816.86 |
| EBIT | -17 030.49 | -11 707.05 | -16 961.00 | -46 549.51 | -55 222.33 |
| Other financial income | 145.60 | 125.32 | 4.00 | 0.08 | 221.84 |
| Other financial expenses | - 249.67 | - 463.09 | - 424.00 | - 108.82 | - 279.81 |
| Pre-tax profit | -17 134.55 | -12 044.82 | -17 381.00 | -46 658.26 | -55 280.30 |
| Income taxes | 3 487.21 | 2 218.51 | 3 379.00 | 5 501.63 | 5 500.00 |
| Net earnings | -13 647.34 | -9 826.31 | -14 002.00 | -41 156.63 | -49 780.30 |
Assets (kDKK)
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Development expenditure | 828.47 | 932.52 | 1 485.00 | 3 090.18 | 4 626.17 |
| Intangible assets total | 828.47 | 932.52 | 1 485.00 | 3 090.18 | 4 626.17 |
| Machinery and equipment | 15.29 | 9.56 | 3.00 | ||
| Tangible assets total | 15.29 | 9.56 | 3.00 | ||
| Other receivables | 90.61 | 92.43 | 158.00 | 199.49 | 180.31 |
| Investments total | 90.61 | 92.43 | 158.00 | 199.49 | 180.31 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 11 616.60 | ||||
| Current amounts owed by group member comp. | 127.00 | ||||
| Prepayments and accrued income | 42.48 | 93.42 | 107.00 | 203.31 | 46.02 |
| Current other receivables | 210.57 | 407.61 | 981.00 | 1 631.68 | 2 828.29 |
| Current deferred tax assets | 3 487.21 | 2 218.51 | 3 378.00 | 5 500.00 | 5 500.00 |
| Short term receivables total | 3 740.27 | 2 719.54 | 4 593.00 | 7 334.99 | 19 990.92 |
| Cash and bank deposits | 2 724.01 | 2 321.93 | 6 452.00 | 2 919.44 | 13 149.75 |
| Cash and cash equivalents | 2 724.01 | 2 321.93 | 6 452.00 | 2 919.44 | 13 149.75 |
| Balance sheet total (assets) | 7 398.66 | 6 075.98 | 12 691.00 | 13 544.10 | 37 947.15 |
Equity and liabilities (kDKK)
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 |
| Share premium account | 17 060.00 | 17 060.00 | |||
| Asset revaluation reserve | 83 635.02 | 160 761.18 | |||
| Retained earnings | 646.61 | -13 000.74 | 24 360.00 | -53 889.36 | -95 045.99 |
| Profit of the financial year | -13 647.34 | -9 826.31 | -14 002.00 | -41 156.63 | -49 780.30 |
| Shareholders equity total | -12 000.74 | -21 827.05 | 11 358.00 | 6 649.03 | 33 994.89 |
| Provisions | 100.00 | ||||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 72.30 | 69.54 | |||
| Current trade creditors | 1 889.40 | 1 204.91 | 1 333.00 | 5 363.01 | 2 439.60 |
| Current owed to group member | 17 437.69 | 26 628.58 | 1.02 | ||
| Other non-interest bearing current liabilities | 1 531.04 | 1 412.67 | |||
| Current liabilities total | 19 399.39 | 27 903.03 | 1 333.00 | 6 895.07 | 3 852.26 |
| Balance sheet total (liabilities) | 7 398.66 | 6 075.98 | 12 691.00 | 13 544.10 | 37 947.15 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
... and more!
No registration needed.